Re: Meckley LM, Veenstra DL. Screening for the alpha-adducin Gly460Trp variant in hypertensive patients: a cost-effectiveness analysis. Pharmacogenet Genom 2006; 16:139-147

Pharmacogenet Genomics. 2006 Aug;16(8):613. doi: 10.1097/01.fpc.0000220568.75219.a9.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Calmodulin-Binding Proteins / genetics*
  • Case-Control Studies
  • Cost-Benefit Analysis*
  • Genetic Testing / economics*
  • Genetic Variation*
  • Genetics, Population
  • Humans
  • Hypertension / genetics*

Substances

  • Calmodulin-Binding Proteins
  • adducin